Our previous work indicated that GT3 has potent anti-proliferative activity in both k-Ras wild type and k-Ras mutated pancreatic cancer cells, but not on non-cancerous pancreatic duct epithelial HPDE-E6E7 cells. Here, KRAS is linked to pancreatic neoplasm.